МИНИСТЕРСТВО ЗДРАВООХРАНЕНИЯ РФ СИБИРСКИЙ ...

189
of High Blood Pressure: the JNC 7 report. National Heart, Lung, and Blood
Institute Joint National Committee on Prevention, Detection, Evaluation, and
Treatment of High Blood Pressure; National High Blood Pressure Education
Program Coordinating Committee. JAMA. 2003; 289: 2560–2572.Erratum in:
JAMA. 2003; 290: 197.
121. Chronobiologic assessment of human blood pressure variation in health
and disease/ F. Halberg, E. Halberg, J. Halberg et al .// Ambulatory Blood
Pressure Monitoring.-Steinkoff-Darmstadt. -1984. – P. 137-156.
122. Clement D.L., De Pue N., Jordanes L.J. et al //Adrenergic and vagal
influences on blood pressure variability// Cln. Exp. Hypertens.-1985. Vol.7.-
P.159-166.
123. Cohn J.N. Structural basis of heart failure: ventricular remodelling and
its pharmacological inhibition // Circulation. – 1995. – Vol. 91. – P. 2504-
2507.
124. Cowley A.W. The concept of autoregulation of total blood flow and its
role in hypertension. In : Topics in hypertension, ed.: Laragh J.H., New
York:Yorke Medicals Books. 1980;184-200.
125. Curry C.L., Robinson H., Brown R. Regression of left ventricular
hypertrophy in patients with assential hypertension/ Results of 6 month
treatment with indapamide- Amer. J. hypertension., 1996;9: 828-832.
126. Dambrauskaite V., Klumbiene J., Zaborskis., et al. Determinants of
blood pressure changes over 12-13 and 26-26 periods// Advances Med
Sci.1992,5,H.76-81
127. Delbarre B, Delbarre G. Role of prostoglandins in the antihypertensive
mecahanisma of indapamide. Clin Exp Hypertens.1990;12:1307.
128. Daniels S.R. Hypertension- indused cardiac damage in children and
adolescents// Blood Pressure Monitoring, 1999.-№ 4- Р.165-170.
129. Dawber T.P., Moore F.E., Mann G.V. Coronary heart disease in the
Framigham Study // J. Publ. Health.-1957.-Vol. 47.-P.art 2.